Authors : Dr. N Shreyas; Dr. Sanath Kumar Shetty; Dr. Sreedhish K; Dr Rashika Saraff; Dr Deeppika Sambhavi AR; Dr Sanjana Arun

Volume/Issue : Volume 9 - 2024, Issue 10 - October

Google Scholar : https://tinyurl.com/yr3be669

Scribd : https://tinyurl.com/39w9yarx

DOI : https://doi.org/10.38124/ijisrt/IJISRT24OCT564

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Pain at the heel affects millions of people globally. The burden of this entity can be virtually visualised by the fact that around 7% of people over 65 years of age report heel pain and tenderness, the main differential diagnosis being plantar fasciitis, amongst others. Plantar fasciitis is one of the most common causes of pain around the heel and plantar aspect of the foot. 80% of patients with heel pain are suffering from plantar fasciitis. Plantar fasciitis has been linked to many mechanical abnormalities and biochemical derangements. The most common biochemical derangement in patients with plantar fasciitis is increased serum uric acid levels. There is increasing evidence that presence of asymptomatic hyperuricemia is a potential risk factor for development of plantar fasciitis. The mean serum uric acid levels in the patients with plantar fasciitis was 7.02 mg/dl, which is in close proximity to the upper limit of normal uric acid levels. Also, the same was true for males and females independently. Even though majority of patients with plantar fasciitis accounting to 52% had serum uric acid levels between 6-8 mg/dl, close to the upper limit of normal value, it cannot be categorised as hyperuricemia. By virtue of this study, we can infer that hyperuricemia per se, cannot be an attributable cause of plantar fasciitis, even though it is known to play an important role in pathogenesis of calcaneal plantar spur formation, which might lead to or augment the pre existing plantar fasciitis.

Keywords : Hyperuricemia, Plantar Fascitis, Gout, Heel Pain, Calcaneum, Associated Factor, Cause.

References :

1. Hicks JH. The mechanics of the foot. II. The plantar aponeurosis and the arch. J Anat 1954; 88: 25–30.
2. Gill LH. Plantar fasciitis: diagnosis and conservative management. J Am Acad Orthop Surg 1997; 5: 109–117.
3. Joosten LA, Crişan TO, Bjornstad P, Johnson RJ: Asymptomatic hyperuricaemia: a silent activator of the innate immune system. Nat Rev Rheumatol. 2020, 16:75-86. 10.1038/s41584-019-0334-3 17.
4. Bardin T: Hyperuricemia starts at 360 micromoles (6 mg/dL). Joint Bone Spine. 2015, 82:141-3. 10.1016/j.jbspin.2015.01.002.
5. Lopes AD, Hespanhol Júnior LC, Yeung SS, Costa LO: What are the main running-related musculoskeletal injuries? A systematic review. Sports Med. 2012, 42:891-905. 10.1007/BF03262301
6. Tenforde AS, Sayres LC, McCurdy ML, Collado H, Sainani KL, Fredericson M: Overuse injuries in high school runners: lifetime prevalence and prevention strategies. PM R. 2011, 3:125-31. 10.1016/j.pmrj.2010.09.009
7. Werner RA, Gell N, Hartigan A, Wiggerman N, Keyserling WM: Risk factors for plantar fasciitis among assembly plant workers. PM R. 2010, 2:110-7. 10.1016/j.pmrj.2009.11.012
8.  Aydeniz A, Gursoy S, Guney E: Which musculoskeletal complications are most frequently seen in type 2 diabetes mellitus?. J Int Med Res. 2008, 36:505-11. 10.1177/147323000803600315
9. Gill LH: Plantar fasciitis: diagnosis and conservative management. J Am Acad Orthop Surg. 1997, 5:109-17. 10.5435/00124635-199703000-00006
10.  Cutts S, Obi N, Pasapula C, Chan W: Plantar fasciitis. Ann R Coll Surg Engl. 2012, 94:539-42. 10.1308/003588412X13171221592456 2023 Yadav et al. Cureus 15(4): e37088. DOI 10.7759/cureus.37088
11.  Arnold MJ, Moody AL: Common running injuries: evaluation and management . Am Fam Physician. 2018, 97:510-6.
12.  Finkenstaedt T, Siriwanarangsun P, Statum S, Biswas R, Anderson KE, Bae WC, Chung CB: The calcaneal crescent in patients with and without plantar fasciitis: an ankle MRI study. AJR Am J Roentgenol. 2018, 211:1075-82. 10.2214/AJR.17.19399.
13. De Miguel E, Puig JG, Castillo C, Peiteado D, Torres RJ, Martín-Mola E: Diagnosis of gout in patients with asymptomatic hyperuricaemia: a pilot ultrasound study. Ann Rheum Dis. 2012, 71:157-8. 10.1136/ard.2011.154997.
14. Taylor WJ, Fransen J, Jansen TL, et al.: Study for updated gout classification criteria: identification of features to classify gout. Arthritis Care Res (Hoboken). 2015, 67:1304-15. 10.1002/acr.22585.
15. Ames PR, Longo UG, Denaro V, Maffulli N: Achilles tendon problems: not just an orthopaedic issue . Disabil Rehabil. 2008, 30:1646-50. 10.1080/09638280701785882.
16. Comberg HU, Schach S: Hyperuricemia is associated with musculo-skeletal pain-results from a crosssectional study. Open Pain J. 2016, 9:15-25. 10.2174/1876386301609010015.
17. Stewart S, Dalbeth N, Vandal AC, Rome K: Characteristics of the first metatarsophalangeal joint in gout and asymptomatic hyperuricaemia: a cross-sectional observational study. J Foot Ankle Res. 2015, 8:41. 10.1186/s13047-015-0091-8.
18.  Andersson HI, Leden I: Serum uric acid predicts changes in reports of non-gouty chronic pain: a prospective study among women with inflammatory and non-inflammatory pain. Rheumatol Int. 2012, 32:193-8. 10.1007/s00296-010-1600-5.
19. Hsu HJ, Yen CH, Hsu KH, et al.: Factors associated with chronic musculoskeletal pain in patients with chronic kidney disease. BMC Nephrol. 2014, 15:6. 10.1186/1471-2369-15-6